1	Hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	0-6	587_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	7-9	587_QUEST_clinical_caseMIR	SENT1	-	-
3	75	75		-	-	10-12	587_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	13-17	587_QUEST_clinical_caseMIR	SENT1	-	-
5	que	que	PR0CN000	-	-	18-21	587_QUEST_clinical_caseMIR	SENT1	-	-
6	recibe	recibir	VMIP3S0	-	-	22-28	587_QUEST_clinical_caseMIR	SENT1	-	-
7	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	29-40	587_QUEST_clinical_caseMIR	SENT1	-	-
8	anticoagulante	anticoagulante	AQ0CS0	C0003280	producto#sustancia	41-55	587_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
9	con	con	SPS00	C0332287	atributo	56-59	587_QUEST_clinical_caseMIR	SENT1	-	-
10	dabigatrán	dabigatrán	VMIF3P0	-	-	60-70	587_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
11	por	por	SPS00	C0678226	atributo	71-74	587_QUEST_clinical_caseMIR	SENT1	-	-
12	una	una		C0205447_1	calificador_1	75-78	587_QUEST_clinical_caseMIR	SENT1	-	-
13	fibrilación	fibrilación	NCFS000	C0004238_1	trastorno_1	79-90	587_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
14	auricular	auricular	NCMS000	C0004238_2	trastorno_2	91-100	587_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
15	.	.	Fp	-	-	100-101	587_QUEST_clinical_caseMIR	SENT1	-	-

1	Acude	acudir	VMIP3S0	-	-	102-107	587_QUEST_clinical_caseMIR	SENT2	-	-
2	al	al	SP+DA	-	-	108-110	587_QUEST_clinical_caseMIR	SENT2	-	-
3	servicio	servicio	NCMS000	-	-	111-119	587_QUEST_clinical_caseMIR	SENT2	-	-
4	de	de	SPS00	C0332285	atributo	120-122	587_QUEST_clinical_caseMIR	SENT2	-	-
5	urgencias	urgencia	NCFP000	C0439609	calificador	123-132	587_QUEST_clinical_caseMIR	SENT2	-	-
6	por	por	SPS00	C0678226	atributo	133-136	587_QUEST_clinical_caseMIR	SENT2	-	-
7	hemorragia	hemorragia	NCFS000	C0017181_1	trastorno_1	137-147	587_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
8	digestiva	digestivo	AQ0FS0	C0017181_2	trastorno_2	148-157	587_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
9	en	en	SPS00	C1720294#C0332285	calificador#atributo	158-160	587_QUEST_clinical_caseMIR	SENT2	-	-
10	forma	forma	NCFS000	C0348078	atributo	161-166	587_QUEST_clinical_caseMIR	SENT2	-	-
11	de	de	SPS00	C0332285	atributo	167-169	587_QUEST_clinical_caseMIR	SENT2	-	-
12	melenas	melena	NCFP000	C0025222#C0222048	trastorno#estructura_corporal	170-177	587_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
13	.	.	Fp	-	-	177-178	587_QUEST_clinical_caseMIR	SENT2	-	-

1	Se	se	P00CN000	-	-	179-181	587_QUEST_clinical_caseMIR	SENT3	-	-
2	realiza	realizar	VMIP3S0	-	-	182-189	587_QUEST_clinical_caseMIR	SENT3	-	-
3	analítica	analítica	NCFS000	-	-	190-199	587_QUEST_clinical_caseMIR	SENT3	-	-
4	en	en	SPS00	C1720294#C0332285	calificador#atributo	200-202	587_QUEST_clinical_caseMIR	SENT3	-	-
5	la	el	DA0FS0	-	-	203-205	587_QUEST_clinical_caseMIR	SENT3	-	-
6	que	que	PR0CN000	-	-	206-209	587_QUEST_clinical_caseMIR	SENT3	-	-
7	presenta	presentar	VMIP3S0	-	-	210-218	587_QUEST_clinical_caseMIR	SENT3	-	-
8	Hb	hb	NC00YL0	-	-	219-221	587_QUEST_clinical_caseMIR	SENT3	-	-
9	6,8	6.8	Z	-	-	222-225	587_QUEST_clinical_caseMIR	SENT3	-	-
10	g	g	NCMN000	-	-	226-227	587_QUEST_clinical_caseMIR	SENT3	-	-
11	/	/	Fh	-	-	227-228	587_QUEST_clinical_caseMIR	SENT3	-	-
12	dL	decilitro	NCMN000	C0439241	calificador	228-230	587_QUEST_clinical_caseMIR	SENT3	-	-
13	,	,	Fc	-	-	230-231	587_QUEST_clinical_caseMIR	SENT3	-	-
14	plaquetas	plaqueta	NCFP000	C0005821	estructura_corporal	232-241	587_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
15	234.000/mm3	234.000/mm3		-	-	242-253	587_QUEST_clinical_caseMIR	SENT3	-	-
16	,	,	Fc	-	-	253-254	587_QUEST_clinical_caseMIR	SENT3	-	-
17	creatinina	creatinina	NC00SC0	C0010294	sustancia	255-265	587_QUEST_clinical_caseMIR	SENT3	-	-
18	1,5	1.5	Z	-	-	266-269	587_QUEST_clinical_caseMIR	SENT3	-	-
19	mg	mg	NCMN000	-	-	270-272	587_QUEST_clinical_caseMIR	SENT3	-	-
20	/	/	Fh	-	-	272-273	587_QUEST_clinical_caseMIR	SENT3	-	-
21	dL	decilitro	NCMN000	C0439241	calificador	273-275	587_QUEST_clinical_caseMIR	SENT3	-	-
22	,	,	Fc	-	-	275-276	587_QUEST_clinical_caseMIR	SENT3	-	-
23	TTPa	tiempo_de_tromboplastina_parcial_activado	NC00YL0	-	-	277-281	587_QUEST_clinical_caseMIR	SENT3	-	-
24	60	60		-	-	282-284	587_QUEST_clinical_caseMIR	SENT3	-	-
25	segundos	segundo	NCMP000	C0205436	calificador	285-293	587_QUEST_clinical_caseMIR	SENT3	-	-
26	,	,	Fc	-	-	293-294	587_QUEST_clinical_caseMIR	SENT3	-	-
27	tiempo	tiempo	NCMS000	C0677634_1	procedimiento_1	295-301	587_QUEST_clinical_caseMIR	SENT3	-	-
28	de	de	SPS00	C0677634_2	procedimiento_2	302-304	587_QUEST_clinical_caseMIR	SENT3	-	-
29	trombina	trombina	NCFS000	C0677634_3	procedimiento_3	305-313	587_QUEST_clinical_caseMIR	SENT3	-	-
30	100	100		-	-	314-317	587_QUEST_clinical_caseMIR	SENT3	-	-
31	segundos	segundo	NCMP000	C0205436	calificador	318-326	587_QUEST_clinical_caseMIR	SENT3	-	-
32	.	.	Fp	-	-	326-327	587_QUEST_clinical_caseMIR	SENT3	-	-

1	Ha	haber	VAIP3S0	-	-	328-330	587_QUEST_clinical_caseMIR	SENT4	-	-
2	tomado	tomar	VMP00SM	C1515187	calificador	331-337	587_QUEST_clinical_caseMIR	SENT4	-	-
3	la	el	DA0FS0	-	-	338-340	587_QUEST_clinical_caseMIR	SENT4	-	-
4	última	último	AO0FS0	-	-	341-347	587_QUEST_clinical_caseMIR	SENT4	-	-
5	dosis	dosis	NCFN000	-	-	348-353	587_QUEST_clinical_caseMIR	SENT4	-	-
6	de	de	SPS00	C0332285	atributo	354-356	587_QUEST_clinical_caseMIR	SENT4	-	-
7	dabigatrán	dabigatrán	VMIF3P0	-	-	357-367	587_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
8	hace	hacer	VMIP3S0	-	-	368-372	587_QUEST_clinical_caseMIR	SENT4	-	-
9	4	4	Z	C1292426_1	calificador_1	373-374	587_QUEST_clinical_caseMIR	SENT4	-	-
10	horas	hora	NCFP000	C1292426_2	calificador_2	375-380	587_QUEST_clinical_caseMIR	SENT4	-	-
11	y	y	CC	C1706368	calificador	381-382	587_QUEST_clinical_caseMIR	SENT4	-	-
12	precisa	precisar	VMIP3S0	-	-	383-390	587_QUEST_clinical_caseMIR	SENT4	-	-
13	realización	realización	NCFS000	-	-	391-402	587_QUEST_clinical_caseMIR	SENT4	-	-
14	de	de	SPS00	C0332285	atributo	403-405	587_QUEST_clinical_caseMIR	SENT4	-	-
15	endoscopia	endoscopia	NCFS000	C0014245	procedimiento	406-416	587_QUEST_clinical_caseMIR	SENT4	-	-
16	urgente	urgente	AQ0CS0	C0439609	calificador	417-424	587_QUEST_clinical_caseMIR	SENT4	-	-
17	.	.	Fp	-	-	424-425	587_QUEST_clinical_caseMIR	SENT4	-	-

1	Qué	qué	DE0CN0	-	-	426-429	587_QUEST_clinical_caseMIR	SENT5	-	-
2	fármaco	fármaco	NCMS000	C0013227	sustancia	430-437	587_QUEST_clinical_caseMIR	SENT5	B-Grp_Medicamento	-
3	utilizar	utilizar	VMN0000	-	-	438-446	587_QUEST_clinical_caseMIR	SENT5	-	-
4	la	lo	PP3FSA00	-	-	446-448	587_QUEST_clinical_caseMIR	SENT5	-	-
5	para	para	SPS00	C0521125	calificador	449-453	587_QUEST_clinical_caseMIR	SENT5	-	-
6	revertir	revertir	VMN0000	-	-	454-462	587_QUEST_clinical_caseMIR	SENT5	-	-
7	el	el	DA0MS0	-	-	463-465	587_QUEST_clinical_caseMIR	SENT5	-	-
8	efecto	efecto	NCMS000	C1704419#C1280500#C1280519	calificador	466-472	587_QUEST_clinical_caseMIR	SENT5	-	-
9	del	del	SP+DA	-	-	473-476	587_QUEST_clinical_caseMIR	SENT5	-	-
10	dabigatrán	dabigatrán	VMIF3P0	-	-	477-487	587_QUEST_clinical_caseMIR	SENT5	B-Grp_Medicamento	-
11	.	.	Fp	-	-	487-488	587_QUEST_clinical_caseMIR	SENT5	-	-

